SPY328.73+5.23 1.62%
DIA271.70+3.60 1.34%
IXIC10,913.56+241.30 2.26%

Citigroup Initiates Coverage On Horizon Therapeutics with Buy Rating, Announces Price Target of $112

Citigroup analyst Navann Ty initiates coverage on Horizon Therapeutics (NASDAQ:HZNP) with a Buy rating and announces Price Target of $112.

 · 
Citigroup analyst Navann Ty initiates coverage on Horizon Therapeutics (NASDAQ:HZNP) with a Buy rating and announces Price Target of $112.